FLGT - Fulgent Genetics, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
618,968
618,968
992,584
421,712
32,528
Cost of revenue
252,067
252,067
215,533
89,807
14,107
Gross profit
366,901
366,901
777,051
331,905
18,421
Operating expenses
Research development
28,910
28,910
24,219
11,580
6,537
Selling general and administrative
149,992
149,992
75,171
30,167
12,312
Total operating expenses
185,399
185,399
101,098
41,747
18,849
Operating income or loss
181,502
181,502
675,953
290,158
-428
Total other income/expenses net
-2,975
-2,975
-
-
-
Income before tax
184,025
184,025
677,300
291,684
409
Income tax expense
42,102
42,102
174,795
72,532
43
Income from continuing operations
141,923
141,923
506,239
214,310
-411
Net income
143,403
143,403
507,364
214,310
-411
Net income available to common shareholders
143,403
143,403
507,364
214,310
-411
Basic EPS
-
4.76
17.25
9.44
-0.02
Diluted EPS
-
4.63
16.38
8.91
-0.02
Basic average shares
-
30,097
29,408
22,694
18,709
Diluted average shares
-
30,964
30,976
24,056
18,709
EBITDA
-
187,999
677,661
290,158
-428